ArticleEuropean heart journal. Case reports2019

Targeting CD20+ B-lymphocytes in inflammatory dilated cardiomyopathy with rituximab improves clinical course: a case series.

Carsten Tschöpe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.